Status:
NOT_YET_RECRUITING
Anemia in Systemic Lupus Erythematosus Specially Refractory Type
Lead Sponsor:
Assiut University
Conditions:
Refractory Anemia in Systemic Lupus Erythematosis
Eligibility:
All Genders
18+ years
Brief Summary
Systemic lupus erythroematosis (SLE) is a systemic autoimmune disease with multisystemic involvement. The condition has several phenotypes, with varying clinical presentations from mild mucocutaneous ...
Detailed Description
Causes of anemia in SLE: Anemia due to chronic disease is the most frequent in patients with SLE, representing approximately one-third of the cases \[2\]. Iron deficiency anemia is also a common cau...
Eligibility Criteria
Inclusion
- -Adult patients (≥18 years) satisfying 2019 EULAR/ACR classification for systemic lupus erythroematosis\[24\].
- Patients satisfying WHO criteria definition of anemia.
Exclusion
- Mixed connective tissue disorders.
- Pregnancy .
Key Trial Info
Start Date :
July 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2024
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT06210295
Start Date
July 9 2024
End Date
December 20 2024
Last Update
June 6 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.